Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone Induction in Newly Diagnosed Myeloma: Analysis of the MIDAS Trial.
Perrot A, Touzeau C, Lambert J, Hulin C, Caillot D, Karlin L, Arnulf B, Rey P, Garderet L, Macro M Dr, Escoffre-Barbe M, Gay J, Chalopin T, Gounot R, Schiano de Colella JM, Tiab M, Mohty M, Kuhnowski F, Fontan J, Manier S, Orsini Piocelle F, Vincent L, Rigaudeau S, Leleu X, Hébraud B, Flet L, Malfuson JV, Jacquet C, Chaoui D, Meuleman N, Abarah W, Montes L, Benramdane R, Sonntag C, Zerazhi H, Danu A, Allangba O, Dib M, Roussel M, Cereja S, Depaus J, Branche N, Demarquette H, Richez V, Bruiec C, Frenzel L, Vekemans MM, Bigot N, Avet-Loiseau H, Corre J, Moreau P. Perrot A, et al. Among authors: arnulf b. Blood. 2025 Jan 22:blood.2024026230. doi: 10.1182/blood.2024026230. Online ahead of print. Blood. 2025. PMID: 39841461
T cell malignancies after CAR T cell therapy in the DESCAR-T registry.
Dulery R, Guiraud V, Choquet S, Thieblemont C, Bachy E, Barete S, Todesco È, Arnulf B, Boissel N, Baruchel A, Bay JO, Le Gouill S, Houot R. Dulery R, et al. Among authors: arnulf b. Nat Med. 2025 Jan 8. doi: 10.1038/s41591-024-03458-w. Online ahead of print. Nat Med. 2025. PMID: 39779930
Renal manifestations of MGUS.
Bridoux F, Nasr SH, Arnulf B, Leung N, Sirac C, Jaccard A. Bridoux F, et al. Among authors: arnulf b. Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):489-498. doi: 10.1182/hematology.2024000573. Hematology Am Soc Hematol Educ Program. 2024. PMID: 39644070 Free PMC article. Review.
Inflammatory Waldenström Macroglobulinemia is associated with clonal hematopoiesis: a multicentric cohort.
Debureaux PE, Poulain S, Harel S, Passet M, Templé M, Friedrich C, Forgeard N, Elessa D, Plas W, Chat L, Lazarian G, Willems L, Royer B, Talbot A, Vaugeois T Dr, Theves F, Terré A, Brignier AC, Malphettes M, Krzisch D, Frenzel L, Davi F, Bravetti C, Nguyen-Khac F, Dupuis J, Cuccuini W, Bouscary D, Hermine O, Roos-Weil D, Kosmider O, Clappier E, Espéli M, Balabanian K, Arnulf B. Debureaux PE, et al. Among authors: arnulf b. Blood. 2024 Nov 21:blood.2024025738. doi: 10.1182/blood.2024025738. Online ahead of print. Blood. 2024. PMID: 39571148
Ixazomib, pomalidomide and dexamethasone in relapsed or refractory multiple myeloma characterized with high-risk cytogenetics: the IFM 2014-01 study.
Bobin A, Manier S, De Keizer J, Srimani JK, Hulin C, Karlin L, Caillot D, Lafon I, Mariette C, Araujo C, Arnulf B, Bareau B, Belhadj K, Benboubker L, Braun T, Calmettes C, Decaux O, Dib M, Demarquette H, Jacquet C, Sonntag C, Godet S, Jaccard A, Lenain P, Macro M, Richez-Olivier V, Tiab M, Vincent L, Zerazhi H, Pétillon MO, Rollet S, Gardeney H, Durand G, Levy A, Touzeau C, Perrot A, Moreau P, Facon T, Corre J, Ragot S, Avet-Loiseau H, Leleu X. Bobin A, et al. Among authors: arnulf b. Haematologica. 2024 Nov 14. doi: 10.3324/haematol.2024.285916. Online ahead of print. Haematologica. 2024. PMID: 39540213 Free article.
Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses.
Ailawadhi S, Arnulf B, Patel K, Cavo M, Nooka AK, Manier S, Callander N, Costa LJ, Vij R, Bahlis NJ, Moreau P, Solomon S, Abrahamsen IW, Baz R, Broijl A, Chen C, Jagannath S, Raje N, Scheid C, Delforge M, Benjamin R, Pabst T, Iida S, Berdeja J, Giralt S, Truppel-Hartmann A, Chen Y, Zhong X, Wu F, Piasecki J, Eliason L, Dhanda D, Felten J, Caia A, Cook M, Popa McKiver M, Rodríguez-Otero P. Ailawadhi S, et al. Among authors: arnulf b. Blood. 2024 Dec 5;144(23):2389-2401. doi: 10.1182/blood.2024024582. Blood. 2024. PMID: 39197072 Clinical Trial.
[Serum hyperviscosity syndrome: Update 2024].
Debureaux PE, Parquet N, Brignier AC, Elessa D, Lemiale V, Siguret V, Quintard PA, Harel S, Royer B, Arnulf B, Talbot A. Debureaux PE, et al. Among authors: arnulf b. Rev Med Interne. 2024 Dec;45(12):759-766. doi: 10.1016/j.revmed.2024.07.008. Epub 2024 Aug 7. Rev Med Interne. 2024. PMID: 39117483 Review. French.
Plasma cell-directed therapies induce profound clinical and durable responses in patients with severe or relapsed/refractory scleromyxedema.
Theves F, Lahuna C, Mahévas T, Harel S, Royer B, Lemiale V, Brignier A, Parquet N, Jachiet M, Bouaziz JD, Elessa D, Arnulf B, Talbot A. Theves F, et al. Among authors: arnulf b. J Eur Acad Dermatol Venereol. 2024 Jul 31. doi: 10.1111/jdv.20257. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39082873
Impact of second autologous stem-cell transplantation at relapsed multiple myeloma: A French multicentric real-life study.
André A, Montes L, Roos-Weil D, Frenzel L, Vignon M, Chalopin T, Debureaux PE, Talbot A, Farge A, Jardin F, Belhadj K, Royer B, Marolleau JP, Arnulf B, Morel P, Harel S. André A, et al. Among authors: arnulf b. Hemasphere. 2024 Jul 29;8(8):e106. doi: 10.1002/hem3.106. eCollection 2024 Aug. Hemasphere. 2024. PMID: 39081803 Free PMC article.
184 results